lemonade inc. - LMND
LMND
Close Chg Chg %
55.04 -0.00 -0.00%
Closed Market
55.04
0.00 (0.00%)
Volume: 1.69M
Last Updated:
May 11, 2026, 3:59 PM EDT
Company Overview: lemonade inc. - LMND
LMND Key Data
| Open $54.65 | Day Range 53.41 - 55.83 |
| 52 Week Range 28.71 - 99.88 | Market Cap $4.23B |
| Shares Outstanding 76.82M | Public Float 66.73M |
| Beta 1.85 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$1.86 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.80M |
LMND Performance
| 1 Week | 0.07% | ||
| 1 Month | 1.10% | ||
| 3 Months | -13.66% | ||
| 1 Year | 77.18% | ||
| 5 Years | -20.73% |
LMND Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
12
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 60.667 | |
| Number of Ratings | 12 | Current Quarters Estimate | -0.563 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | -1.734 | |
| Last Quarter’s Earnings | -0.47 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -2.24 | Next Fiscal Year Estimate | -0.823 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 13 | 12 | 13 | 13 |
| Mean Estimate | -0.56 | -0.53 | -1.73 | -0.82 |
| High Estimates | -0.48 | -0.38 | -1.54 | -0.27 |
| Low Estimate | -0.67 | -0.73 | -1.97 | -1.31 |
| Coefficient of Variance | -8.77 | -19.86 | -9.13 | -36.10 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 3 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 5 | 5 | 6 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 3 | 3 | 3 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Lemonade Inc. - LMND
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Lemonade Inc. - LMND
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 31, 2026 | Maria Angelidou-Smith Director | 14,896 | Open market or private purchase of non-derivative security Non-derivative transaction at $55.3 per share | 823,748.80 |
| Mar 31, 2026 | Maria Angelidou-Smith Director | 38,944 | Open market or private purchase of non-derivative security Non-derivative transaction at $55.7 per share | 2,169,180.80 |
| Jan 14, 2026 | John Peters Chief Insurance Officer | 79,228 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $5.26 per share | 416,739.28 |
| Jan 14, 2026 | John Peters Chief Insurance Officer | 10,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 3, 2025 | Geoff Seeley Director | 3,119 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 10, 2025 | Timothy E. Bixby Chief Financial Officer | 274,393 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $23.69 per share | 6,500,370.17 |
| Jul 10, 2025 | Timothy E. Bixby Chief Financial Officer | 269,393 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $42.28 per share | 11,389,936.04 |
| Jul 10, 2025 | Timothy E. Bixby Chief Financial Officer | 263,393 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $42.5 per share | 11,194,202.50 |
| Jul 10, 2025 | Timothy E. Bixby Chief Financial Officer | 289,300 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |